Korean J Med.  2013 Jul;85(1):15-21.

Effects of Antiplatelet Drugs in Cardiovascular Prevention

Affiliations
  • 1Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea. hylee612@snu.ac.kr

Abstract

Hypertension and atherosclerosis are associated with a prothrombotic or hypercoagulable state, as evident by abnormalities of haemostasis, platelets and endothelial function. Therefore, in high risk hypertensive patients, use of antiplatelet agent might be beneficial in preventing thrombotic complication such as myocardial infarction and ischemic stroke. Aspirin 100 mg daily is recommended for hypertensive patients who have one of the following categories: secondary prevention +/- cardiovascular complications, primary prevention having one of risk factors such as age > 50 years + target organ damage, a 10-year CHD risk > 15%, or type II diabetes mellitus. However, it should kept in mind that aspirin treatment be initiated after stabilization of blood pressure < 150/90 mmHg.

Keyword

Hypertension; Antiplatelet; Aspirin

MeSH Terms

Aspirin
Atherosclerosis
Blood Platelets
Blood Pressure
Diabetes Mellitus
Humans
Hypertension
Myocardial Infarction
Platelet Aggregation Inhibitors
Primary Prevention
Risk Factors
Secondary Prevention
Stroke
Aspirin
Platelet Aggregation Inhibitors
Full Text Links
  • KJM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr